Chemistry

Search results

• NIHR: World-first trial of gene therapy to cure children with rare type of genetic deafness begins

  Manohar Lal, B.

  10/11/23 → 10/13/23

  2 items of Media coverage

  Press/Media: Research

• Regeneron Compendium - A Snapshot as of December 31, 2023

  Manohar Lal, B.

  1/2/24

  3 items of Media coverage

  Press/Media: Research

• Weekly: Regeneron (REGN: $846.72) in bottom 1% performers of NASDAQ-100 Index in past week; -$12.42 [1.4%]

  Manohar Lal, B.

  12/25/23

  1 item of Media coverage

  Press/Media: Research

• Cambridge University Hospitals NHS Foundation Trust: World-first trial to provide hearing for children with rare type of genetic hearing loss launches in Cambridge

  Manohar Lal, B.

  10/11/23

  1 item of Media coverage

  Press/Media: Research

• New Findings from University of Cambridge in the Area of Cochlear Implants Described (Speedcap: an Efficient Method for Estimating Neural Activation Patterns Using Electrically Evoked Compound Action-potentials In Cochlear Implant Users)

  Manohar Lal, B.

  6/5/23

  1 item of Media coverage

  Press/Media: Research

• Regeneron (REGN) Reports Prelim Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss

  Manohar Lal, B.

  10/26/23

  2 items of Media coverage

  Press/Media: Research

• Monthly: Regeneron (REGN: $878.29) rises 9% on high volatility in December 2023

  Manohar Lal, B.

  1/2/24

  1 item of Media coverage

  Press/Media: Research

• Weekly: Regeneron (REGN: $798.30) increases on weak volume; +$1.76 [0.2%]

  Manohar Lal, B.

  11/25/23

  1 item of Media coverage

  Press/Media: Research

• Monthly: Regeneron (REGN: $823.81) adds $5 billion in MCap in November, leads Medical/Biomedical sector gains

  Manohar Lal, B.

  12/1/23

  1 item of Media coverage

  Press/Media: Research

• Gene therapy could cure a certain type of deafness

  Manohar Lal, B.

  10/16/23

  1 item of Media coverage

  Press/Media: Research

• Maiden gene therapy to cure rare type deafness in kids begins

  Manohar Lal, B.

  10/15/23

  1 item of Media coverage

  Press/Media: Research

• Early result backs Regeneron’s deafness gene therapy

  Manohar Lal, B.

  10/27/23

  1 item of Media coverage

  Press/Media: Research

• Landmark Gene Therapy Clinical Trial Aims to Restore Hearing in Children with Genetic Hearing Loss

  Manohar Lal, B.

  10/13/23

  1 item of Media coverage

  Press/Media: Research

• Weekly: Regeneron (REGN: $798.94) drops 2.2% on average volume; -$17.96 [2.2%]

  Manohar Lal, B.

  11/11/23

  1 item of Media coverage

  Press/Media: Research

• Weekly: Regeneron (REGN: $816.90) climbs 5.4% on below average volume; +$41.72 [5.4%]

  Manohar Lal, B.

  11/4/23

  1 item of Media coverage

  Press/Media: Research

• Weekly: Regeneron (REGN: $846.72) in bottom 1% performers of NASDAQ-100 Index in past week; -$12.42 [1.4%]

  Manohar Lal, B.

  12/23/23

  1 item of Media coverage

  Press/Media: Research

• Bonds Weekly: Regeneron Pharmaceuticals Inc bonds YTM increases by 15 basis points

  Manohar Lal, B.

  1/8/24

  1 item of Media coverage

  Press/Media: Research

• Bonds Weekly: Regeneron Pharmaceuticals Inc bonds YTM decreases by 30 basis points

  Manohar Lal, B.

  12/4/23

  1 item of Media coverage

  Press/Media: Research

• MY01 Highlighted In Orthopaedic Trauma Association Symposium Focused On Acute Compartment Syndrome'

  Ross K., L.

  10/15/22

  1 item of Media coverage

  Press/Media: Research

• CATHERINE SHEPHERD: Hype versus Hope in dementia research

  Sultan, D., Susan K., B. & Melissa Kathryn, A.

  12/20/23

  1 item of Media coverage

  Press/Media: Research